Advertisement

Topics

Advertisement

Solid Tumors

Hematologic Malignancies

Issues in Oncology

Supportive Care

Advertisement

Advertisement

Apr

23

Today In Oncology

Does Intake of Dietary Fat Increase Risk of Skin Cancer?

FDA Approves Pembrolizumab Plus Axitinib for First-Line Treatment of Advanced Renal Cell Carcinoma

Cervical Cancer Subtype Rising in Some Populations

Deep-Learning Model May Improve Predictions of Survival and Specific Outcomes in Lung Cancer

KEYNOTE-042: Pembrolizumab vs Chemotherapy in Previously Untreated Locally Advanced or Metastatic NSCLC With PD-L1 Expression ≥ 1%

;

Advertisement

Most Read Stories

Report Examines Shortages of Oncologists, Variation in Cancer Rates

Primary Surgery Outcomes in MRI-Based ‘Good-Prognosis’ Rectal Cancer

Addition of Radiotherapy After Breast-Conserving Surgery Based on Level of Tumor-Infiltrating Lymphocytes

Addition of Bortezomib to R-CHOP in DLBCL Subtypes Identified With Gene-Expression Profiling

KEYNOTE-158: Pembrolizumab in Previously Treated Advanced Cervical Cancer

Most Viewed Videos

Robert A. Figlin, MD, on RCC: Results From the ADAPT Trial

Wells A. Messersmith, MD, on Managing Metastatic Colorectal Cancer: NCCN Guidelines Update

Heinz-Josef Lenz, MD, on Pancreatic Cancer Tumor Profiling and Treatment Response: Results From the COMPASS Trial

Elizabeth A. Mittendorf, MD, PhD, on Breast Cancer Immunotherapy: Building on Recent Successes

Rana R. McKay, MD, on Renal Cell Carcinoma: Results From a Trial on Atezolizumab and Bevacizumab

© 2019 HSP News Service, L.L.C.